lunes, 14 de noviembre de 2022

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome - The Lancet Rheumatology

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario